308 related articles for article (PubMed ID: 27531667)
1. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation.
Chen CC; Chang KC; Medeiros LJ; Lee JY
J Cutan Pathol; 2016 Dec; 43(12):1102-1111. PubMed ID: 27531667
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases.
Cho KH; Lee SH; Kim CW; Jeon YK; Kwon IH; Cho YJ; Lee SK; Suh DH; Chung JH; Yoon TY; Lee SJ
Br J Dermatol; 2004 Aug; 151(2):372-80. PubMed ID: 15327544
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
[TBL] [Abstract][Full Text] [Related]
5. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.
Chen CC; Chang KC; Medeiros LJ; Lee JY
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336
[TBL] [Abstract][Full Text] [Related]
6. The association of latent Epstein-Barr virus infection with hydroa vacciniforme.
Iwatsuki K; Xu Z; Takata M; Iguchi M; Ohtsuka M; Akiba H; Mitsuhashi Y; Takenoshita H; Sugiuchi R; Tagami H; Kaneko F
Br J Dermatol; 1999 Apr; 140(4):715-21. PubMed ID: 10233328
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up.
Verneuil L; Gouarin S; Comoz F; Agbalika F; Creveuil C; Varna M; Vabret A; Janin A; Leroy D
Br J Dermatol; 2010 Jul; 163(1):174-82. PubMed ID: 20367637
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children.
Xu Z; Lian S
Pediatr Dermatol; 2010; 27(5):463-9. PubMed ID: 20497358
[TBL] [Abstract][Full Text] [Related]
9. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
10. Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma.
Plaza JA; Sangueza M
Am J Dermatopathol; 2015 Jan; 37(1):20-5. PubMed ID: 25162933
[TBL] [Abstract][Full Text] [Related]
11. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China.
Wang X; Liang Y; Yang Y; Li W; Wang G; Wang S; Li Y; Zhang M
J Dermatol; 2021 Sep; 48(9):1315-1326. PubMed ID: 33982815
[TBL] [Abstract][Full Text] [Related]
12. Hydroa Vacciniforme-Like EBV-Positive Cutaneous T-Cell Lymphoma, First Report of 2 Cases in Ecuador.
Montalvo N; Redrobán L
Am J Dermatopathol; 2016 May; 38(5):e57-9. PubMed ID: 26913846
[TBL] [Abstract][Full Text] [Related]
13. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
[TBL] [Abstract][Full Text] [Related]
14. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
[TBL] [Abstract][Full Text] [Related]
15. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.
Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K
J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643
[TBL] [Abstract][Full Text] [Related]
16. Hydroa Vacciniforme-Like T-Cell Lymphoma: A Further Brazilian Case.
Miranda MFR; Santos JEBD; Müller SFR; Bittencourt MJS; Brito AC; Barros Junior JNDS; Xerfan EMS
Am J Dermatopathol; 2018 Mar; 40(3):201-204. PubMed ID: 28248720
[TBL] [Abstract][Full Text] [Related]
17. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
[TBL] [Abstract][Full Text] [Related]
18. Hydroa vacciniforme-like lymphoproliferative disorder: Clinicopathologic study of 41 cases.
Liu Y; Ma C; Wang G; Wang L
J Am Acad Dermatol; 2019 Aug; 81(2):534-540. PubMed ID: 30654082
[TBL] [Abstract][Full Text] [Related]
19. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.
Quintanilla-Martinez L; Ridaura C; Nagl F; Sáez-de-Ocariz M; Durán-McKinster C; Ruiz-Maldonado R; Alderete G; Grube P; Lome-Maldonado C; Bonzheim I; Fend F
Blood; 2013 Oct; 122(18):3101-10. PubMed ID: 23982171
[TBL] [Abstract][Full Text] [Related]
20. Hydroa vacciniforme-like lymphoproliferative disorder in Korea.
Han B; Hur K; Ohn J; Kim TM; Jeon YK; Kim YC; Mun JH
Sci Rep; 2020 Nov; 10(1):19294. PubMed ID: 33168864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
